• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Boehringer Ingelheim reports positive results from trial of HER2 lung cancer drug

cafead

Administrator
Staff member
  • cafead   Sep 10, 2024 at 08:52: AM
via German pharmaceutical company Boehringer Ingelheim has reported positive outcomes from the first cohort of Beamion LUNG-1, a two-part trial analysing zongertinib for treating non-small cell lung cancer (NSCLC).

article source
 

<